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Introduction
Ectopic varices are a rare cause of gastrointestinal (GI) bleeding
that may occur in the GI tract outside the esophageal and gastric distribution [1]. The majority of these cases are rectal varices in cirrhotic patients with portal hypertension. Colonic
varices (CV) are less common than rectal, duodenal, and smallbowel varices [2]. There are no clear guidelines for managing CV
given the rarity of this finding [3]. We report a case of massive
lower-GI bleeding due to CV in a patient with non-alcoholic
steatohepatitis (NASH) without cirrhosis or portal hypertension
secondary to porto-mesenteric venous thrombosis that was
successfully treated with superior mesenteric venous (SMV)
stenting. Given the extent of the mesenteric thrombosis, treatment modalities like transjugular intrahepatic portosystemic
shunt (TIPS) and balloon-occluded retrograde transvenous obliteration (BRTO) were not possible.

Case report
A 57-year-old man with NASH without cirrhosis presented to a
satellite hospital with acute onset of painless hematochezia for
1 day. He had unprovoked deep venous thrombosis with a negative hypercoagulable workup and portal-vein thrombosis on
Apixaban diagnosed 18 months prior to presentation. He was
tachycardic and mildly hypotensive. There was no evidence of
chronic liver disease on exam. The hemoglobin level was 130 g/
L and subsequently decreased to 80 g/L, while the platelet count

was 160  109/L. Laboratory tests revealed the following values:
INR, 1.13; lactate, 1 mmol/L; albumin, 3.7 g/dl; and liver enzymes
were within normal limits. Anticoagulation was discontinued
and he was resuscitated using intravenous (IV) crystalloids.
Esophagogastroduodenoscopy (EGD) revealed small nonbleeding esophageal varices. Colonoscopy revealed a complex
ascending colonic varix with active bleeding (Figure 1).
He was treated with IV octreotide at the satellite hospital at
which he presented and then transferred to our tertiary institution for escalation of care. Liver-protocol computed tomography
(CT) was performed for TIPS evaluation and revealed a steatotic
liver and collateralized chronically thrombosed SMV with patent portal vein. He was deemed not to be a candidate for either
TIPS or BRTO in the setting of chronic SMV thrombosis. Colonic
resection was not recommended, since it was unlikely to prevent future bleeding with significant collaterals.
He continued to have hematochezia with Hgb nadir of 78 g/L.
A trans-hepatic portogram performed by interventional radiology revealed an elevated absolute portal pressure of 18 mmHg.
Digital subtraction images confirmed the site of the SMV occlusion at the confluence of two large SMV branches, in addition to
retrograde flow through the large right CV. The occluded SMV
was cannulated through a left patent branch using a 4-French
angled glide catheter and a stiff Glidewire. A Cobra 2 catheter
and a stiff Glidewire were used to cannulate the right SMV
branch at the confluence. Recanalization of the occluded SMV
(Supplementary Figure 1) was achieved by using 5  40 mm balloon angioplasty to 5 mm, then two overlapping 10  40 mm
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Conclusions
Figure 1. Endoscopic view of bleeding colonic varices.

self-expanding stents were successfully deployed into the origin
of the right SMV branch, extending proximally into the portal
splenic confluence. The stents were then post-dilated using balloon angioplasty to 8 and 10 mm. Follow-up venography
showed antegrade flow in the right SMV branch into the SMV
stent with a marked reduction in filling of the right CV
(Supplementary Figure 2). The procedure was terminated after
restoration of the SMV flow and the portal pressure was not
measured post-procedurally. Liver biopsy showed steatohepatitis with stage 2/4 fibrosis. Apixaban and low-dose aspirin were
started. Two months after discharge, the patient had no recurrent bleeding and CT showed patent SMV stents
(Supplementary Figure 3). A plan for surveillance was determined using cross-sectional imaging every 6 months for 2 years.

Discussion
CV are dilated portosystemic venous collaterals in the colonic
submucosa that comprise a rare cause of GI bleeding. CV have a
reported incidence rate of 0.07% in the general population [4].
They are usually located in the distribution of the inferior mesenteric vein (IMV) (66%), SMV distribution (26%), and mixed supply areas [5]. CV are most commonly diagnosed in cirrhotic
patients with portal hypertension [6]. Non-cirrhotic etiologies
include congestive heart failure, portomesenteric venous compromise, splenic venous thrombosis, inherited vascular anomalies, or they can be idiopathic [7].
Patients with CV usually present with intermittent hematochezia or massive rectal bleeding. The gold standard for diagnosis is selective mesenteric angiography, which can be
therapeutic and diagnostic [4]. However, colonoscopy is more
commonly performed as a first step for lower-GI-bleeding evaluation. Detection via colonoscopy can be obscured by polyps,
malignant masses, active bleeding, or may be missed if the varices are flattened with insufflation [8].
Endoscopic therapies, TIPS, BRTO, angiographic embolization, and even colonic resection have been described in CV
management [9]. However, due to limited data, standard management is still not well defined. The treatment typically focuses on symptom control and management of the underlying
medical conditions causing the varices. Endoscopic management includes injections of cyanoacrylate, sclerotherapy, and

CV may present with lower-GI bleeding, ranging from mild to
life threatening, which makes early diagnosis of extreme importance. Management differs based on the available medical expertise, the underlying etiology of the varices, and the patient’s
clinical presentation. Further studies are needed to establish a
clear stepwise approach for management of these rare but dangerous findings. In cases of CV with severe mesenteric thrombosis and portal hypertension, treatment with an SMV stent may
be considered.

Supplementary Data
Supplementary data is available at Gastroenterology Report
online.
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